Hint mode is switched on Switch off
For swift navigation between sections

Caliway Biopharmaceuticals
LEI 984500D2D587B98A7B13

PDF download

Choose all Reset all
Download Cancel
Organization name
Caliway Biopharmaceuticals Co Ltd
Country name
Taiwan
Country of registration
Taiwan
Industry
Medical Services
Public debt
-
Welcome to Cbonds
New to Cbonds? · Take a 90-second tour of the platform.

Discover what you can do with Cbonds

Everything you need for fixed income research and monitoring.

  • 00:23 Coverage
  • 00:40 Bond screener
  • 00:54 Parameters
  • 01:10 Watchlist, Mobile app
  • 01:15 Excel Add-in
Get access Watch full tour

Latest data on

Get access to the largest financial database

Try in 7-days Demo access

Free for company representative

  • Evaluate advanced analytical tools
  • Get full online access to the database
  • Try our powerful bond screener
  • Track bond prices from 400+ sources

Get access to the largest financial database

Representative of the company 7 days FREE trial

Professional access to the data

Private investor

Individual access

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

Caliway Biopharmaceuticals Co., Ltd. focuses on breakthrough medical aesthetics and inflammatory medicine discovery of small molecule therapeutics. The Company develops CBL-514 to treat subcutaneous fat. Caliway Biopharmaceuticals conducts businesses across worldwide.

Awards

Documentation

Stocks

Public debt by currencies

Show more Hide

Codes

  • LEI
    984500D2D587B98A7B13
  • NACE
    *** ***
  • NAICS
    *** ***
Registration is required to get access.